Markets:

Overview

News

Currencies

International

Treasuries

Fulcrum Therapeutics, Inc. - Common Stock (NQ:FULC)

10.34 -0.00 (-0.05%)

Streaming Delayed Price Updated: 12:02 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulcrum Therapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stocks That Hit 52-Week Highs On Monday ↗

August 23, 2021

Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

August 17, 2021

Citigroup cut the price target on Wix.com Ltd. (NYSE:WIX...

Via Benzinga

The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among...

Via Talk Markets

Topics Initial Public Offering

The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...

Via Benzinga

Topics Initial Public Offering

Analyzing Fulcrum Therapeutics's Unusual Options Activity ↗

August 12, 2021

On Thursday, shares of Fulcrum Therapeutics (NASDAQ:FULC)...

Via Benzinga

Why Are Fulcrum Therapeutics Shares Trading Higher Today? ↗

August 11, 2021

Fulcrum Therapeutics Inc (NASDAQ:FULC) is trading higher a...

Via Benzinga

Analyzing Fulcrum Therapeutics's Unusual Options Activity ↗

August 10, 2021

On Tuesday, shares of Fulcrum Therapeutics (NASDAQ:FULC) ...

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

Mid-Afternoon Market Update: Dow Drops 50 Points; IEC Electronics Shares Spike Higher ↗

August 12, 2021

Toward the end of trading Thursday, the Dow traded down 0.14% to 35,435.25 while the NASDAQ rose 0.29% to 14,808.42. The S&P also rose, gaining 0.19% to 4,456.37. The U.S. has...

Via Benzinga

Topics Stocks

66 Biggest Movers From Yesterday ↗

August 12, 2021

Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic...

Via Benzinga

Topics Initial Public Offering

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Why Fulcrum Therapeutics Popped Again on Tuesday ↗

August 11, 2021

Compelling clinical-trial data that could validate the company's unique approach to new drug development inspired a slew of analyst upgrades.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2021 ↗

August 11, 2021

Upgrades According to Barclays, the prior rating for Albertsons Companies Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 11, 2021

Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

85 Biggest Movers From Yesterday ↗

August 11, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 10, 2021

Gainers CohBar (NASDAQ:CWBR) shares incr...

Via Benzinga

FULC Stock: The Trial News Sending Fulcrum Therapeutics Skyrocketing ↗

August 10, 2021

Shares of FULC stock are skyrocketing higher today on reports of positive results for the company's sickle cell treatment trial.

Via InvestorPlace

Mid-Afternoon Market Update: 3D Systems Surges On Upbeat Earnings; Katapult Shares Drop ↗

August 10, 2021

Toward the end of trading Tuesday, the Dow traded up 0.49% to 35,274.95 while the NASDAQ fell 0.41% to 14,799.03. The S&P also rose, gaining 0.18% to 4,440.12. The U.S. has...

Via Benzinga

Topics Stocks

Why Fulcrum Therapeutics Shares Are Soaring Today ↗

August 10, 2021

Fulcrum Therapeutics Inc (NASDAQ: FULC) is surging higher Tuesday after the company reported results from its Phase 1 study of FTX-6058 for sickle cell disease showed...

Via Benzinga

Fulcrum Stock Nearly Triples — Why Shares Went Gangbusters On Sickle Cell Drug ↗

August 10, 2021

Fulcrum Therapeutics unveiled positive results for its sickle cell disease drug, and the biotech stock more than doubled to a 13-month high.

Via Investor's Business Daily

Mid-Day Market Update: Crude Oil Rises Over 3%; comScore Shares Plummet ↗

August 10, 2021

Midway through trading Tuesday, the Dow traded up 0.37% to 35,231.28 while the NASDAQ fell 0.62% to 14,767.78. The S&P also fell, dropping 0.01% to 4,432.24. The U.S. has the...

Via Benzinga

Topics Stocks

54 Stocks Moving In Tuesday's Mid-Day Session ↗

August 10, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...

Via Benzinga

Here's Why Fulcrum Therapeutics Stock Is Shooting Higher Today ↗

August 10, 2021

A positive trial readout suggests the company's new drug discovery engine has more potential than expected.

Via The Motley Fool

Mid-Morning Market Update: Markets Open Higher; Sysco Tops Q4 Views ↗

August 10, 2021

Following the market opening Tuesday, the Dow traded up 0.47% to 35,266.74 while the NASDAQ rose 0.04% to 14,866.20. The S&P also rose, gaining 0.28% to 4,444.54. The U.S. has...

Via Benzinga

Topics Stocks

Fulcrum Shares Are Trading Higher As Candidate For Inherited Blood Disorders Shows Proof Of Mechanism, Biology In Early-Stage Study ↗

August 10, 2021

Fulcrum Therapeutics Inc (NASDAQ: FULC) has announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers. FTX-6058 is...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 10, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.